Imperagen raises £5 million to use quantum physics, AI on enzyme engineering

Biotech company Imperagen has secured £5 million ($6.7 million) in seed funding led by PXN Ventures to advance enzyme engineering using quantum physics and artificial intelligence. The round also includes participation from investors IQ Capital and Northern Gritstone.